Wei‐Bang Yu
-
- Phagocytosis and Immune Regulation 6
- Immune cells in cancer 3
-
- Erythrocyte Function and Pathophysiology 3
-
- Antiplatelet Therapy and Cardiovascular Diseases 2
-
- Metabolomics and Mass Spectrometry Studies 1
- Extracellular vesicles in disease 1
- Ginseng Biological Effects and Applications 1
- Genomics, phytochemicals, and oxidative stress 1
Wei‐Bang Yu
14 papers receiving 391 citations
Peers
Comparison fields: 5 of 78
- Immunology 98
- Pharmacology 40
- Internal Medicine 14
- Complementary and alternative medicine 27
- Molecular Medicine 16
Countries citing papers authored by Wei‐Bang Yu
This map shows the geographic impact of Wei‐Bang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Bang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Bang Yu more than expected).
Fields of papers citing papers by Wei‐Bang Yu
This network shows the impact of papers produced by Wei‐Bang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Bang Yu. The network helps show where Wei‐Bang Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei‐Bang Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2022 | 28 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 27 | |
| 7 | 2020 | 35 | |
| 8 | 2020 | 42 | |
| 9 | 2020 | 57 | |
| 10 | 2019 | 27 | |
| 11 | 2018 | 16 | |
| 12 | 2018 | 30 | |
| 13 | 2018 | 49 | |
| 14 | 2017 | 34 | |
| 15 | 2016 | 46 |
About Wei‐Bang Yu
Wei‐Bang Yu is a scholar working on Immunology, Physiology and Molecular Medicine, having authored 15 papers that have together received 402 indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (6 papers), Erythrocyte Function and Pathophysiology (3 papers), Immune cells in cancer (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Metabolomics and Mass Spectrometry Studies (1 paper), Extracellular vesicles in disease (1 paper), Ginseng Biological Effects and Applications (1 paper) and Genomics, phytochemicals, and oxidative stress (1 paper). The work is most often cited by research in Immunology (98 citations), Pharmacology (40 citations) and Internal Medicine (14 citations). Wei‐Bang Yu has collaborated with scholars based in China and Macao. Frequent co-authors include Jin‐Jian Lu, Min Huang, Xiuping Chen, Chuncao Xu, Jiajie Shi, Mu‐Yang Huang, Jing Jin, Zhongxiang Zhao, Jing Jin and Di Cao. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Acta Pharmacologica Sinica, Current Cancer Drug Targets, Acta Pharmaceutica Sinica B and Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.